Alleged medical abandonment in chronic opioid analgesic therapy: Case report

David A Fishbain, John E Lewis, Jinrun Gao, Brandly Cole, Rennee Steele Rosomoff

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objectives. The objectives of this medicolegal case report were the following: 1) present details of a chronic pain patient (CPP) on chronic opioid analgesic therapy (COAT), who diverted her opioids and was terminated from treatment, and subsequently committed suicide; 2) present both the plaintiff's and defendant's (the COAT prescriber) expert witnesses' opinions as to the allegation of medical abandonment of this patient and other allegations; and 3) based on these opinions, to develop some recommendations as to how pain physicians can minimize their medicolegal risk when termination of the physician-patient relationship is warranted. Methods. This is a case report of a CPP treated by a pain physician who demonstrated aberrant drug-related behaviors and required large doses of controlled-release oxycodone. Results. Differences between the plaintiff's and defendant's experts' opinions are presented by utilizing the COAT literature. Options for avoiding allegations of abandonment are proposed. Conclusions. To avoidand protect themselves against potential abandonment allegations when termination of the physician-patient relationship is warranted, physicians are advised to consider following the outlined procedures.

Original languageEnglish
Pages (from-to)722-729
Number of pages8
JournalPain Medicine
Volume10
Issue number4
DOIs
StatePublished - Jun 18 2009

Fingerprint

Opioid Analgesics
Expert Testimony
Physician-Patient Relations
Physicians
Chronic Pain
Refusal to Treat
Oxycodone
Pain
Therapeutics
Suicide
Pharmaceutical Preparations

Keywords

  • Abandonment
  • Aberrant drug-related behaviors
  • Breaches of standards
  • Chronic opioid analgesic therapy
  • Chronic Pain
  • Death
  • Diversion
  • Intractable pain
  • Opioids
  • Standards of medical care
  • Suicide

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Fishbain, D. A., Lewis, J. E., Gao, J., Cole, B., & Rosomoff, R. S. (2009). Alleged medical abandonment in chronic opioid analgesic therapy: Case report. Pain Medicine, 10(4), 722-729. https://doi.org/10.1111/j.1526-4637.2009.00620.x

Alleged medical abandonment in chronic opioid analgesic therapy : Case report. / Fishbain, David A; Lewis, John E; Gao, Jinrun; Cole, Brandly; Rosomoff, Rennee Steele.

In: Pain Medicine, Vol. 10, No. 4, 18.06.2009, p. 722-729.

Research output: Contribution to journalArticle

Fishbain, DA, Lewis, JE, Gao, J, Cole, B & Rosomoff, RS 2009, 'Alleged medical abandonment in chronic opioid analgesic therapy: Case report', Pain Medicine, vol. 10, no. 4, pp. 722-729. https://doi.org/10.1111/j.1526-4637.2009.00620.x
Fishbain, David A ; Lewis, John E ; Gao, Jinrun ; Cole, Brandly ; Rosomoff, Rennee Steele. / Alleged medical abandonment in chronic opioid analgesic therapy : Case report. In: Pain Medicine. 2009 ; Vol. 10, No. 4. pp. 722-729.
@article{61fa237a1dca4351ad973b0e2c610f1d,
title = "Alleged medical abandonment in chronic opioid analgesic therapy: Case report",
abstract = "Objectives. The objectives of this medicolegal case report were the following: 1) present details of a chronic pain patient (CPP) on chronic opioid analgesic therapy (COAT), who diverted her opioids and was terminated from treatment, and subsequently committed suicide; 2) present both the plaintiff's and defendant's (the COAT prescriber) expert witnesses' opinions as to the allegation of medical abandonment of this patient and other allegations; and 3) based on these opinions, to develop some recommendations as to how pain physicians can minimize their medicolegal risk when termination of the physician-patient relationship is warranted. Methods. This is a case report of a CPP treated by a pain physician who demonstrated aberrant drug-related behaviors and required large doses of controlled-release oxycodone. Results. Differences between the plaintiff's and defendant's experts' opinions are presented by utilizing the COAT literature. Options for avoiding allegations of abandonment are proposed. Conclusions. To avoidand protect themselves against potential abandonment allegations when termination of the physician-patient relationship is warranted, physicians are advised to consider following the outlined procedures.",
keywords = "Abandonment, Aberrant drug-related behaviors, Breaches of standards, Chronic opioid analgesic therapy, Chronic Pain, Death, Diversion, Intractable pain, Opioids, Standards of medical care, Suicide",
author = "Fishbain, {David A} and Lewis, {John E} and Jinrun Gao and Brandly Cole and Rosomoff, {Rennee Steele}",
year = "2009",
month = "6",
day = "18",
doi = "10.1111/j.1526-4637.2009.00620.x",
language = "English",
volume = "10",
pages = "722--729",
journal = "Pain Medicine",
issn = "1526-2375",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Alleged medical abandonment in chronic opioid analgesic therapy

T2 - Case report

AU - Fishbain, David A

AU - Lewis, John E

AU - Gao, Jinrun

AU - Cole, Brandly

AU - Rosomoff, Rennee Steele

PY - 2009/6/18

Y1 - 2009/6/18

N2 - Objectives. The objectives of this medicolegal case report were the following: 1) present details of a chronic pain patient (CPP) on chronic opioid analgesic therapy (COAT), who diverted her opioids and was terminated from treatment, and subsequently committed suicide; 2) present both the plaintiff's and defendant's (the COAT prescriber) expert witnesses' opinions as to the allegation of medical abandonment of this patient and other allegations; and 3) based on these opinions, to develop some recommendations as to how pain physicians can minimize their medicolegal risk when termination of the physician-patient relationship is warranted. Methods. This is a case report of a CPP treated by a pain physician who demonstrated aberrant drug-related behaviors and required large doses of controlled-release oxycodone. Results. Differences between the plaintiff's and defendant's experts' opinions are presented by utilizing the COAT literature. Options for avoiding allegations of abandonment are proposed. Conclusions. To avoidand protect themselves against potential abandonment allegations when termination of the physician-patient relationship is warranted, physicians are advised to consider following the outlined procedures.

AB - Objectives. The objectives of this medicolegal case report were the following: 1) present details of a chronic pain patient (CPP) on chronic opioid analgesic therapy (COAT), who diverted her opioids and was terminated from treatment, and subsequently committed suicide; 2) present both the plaintiff's and defendant's (the COAT prescriber) expert witnesses' opinions as to the allegation of medical abandonment of this patient and other allegations; and 3) based on these opinions, to develop some recommendations as to how pain physicians can minimize their medicolegal risk when termination of the physician-patient relationship is warranted. Methods. This is a case report of a CPP treated by a pain physician who demonstrated aberrant drug-related behaviors and required large doses of controlled-release oxycodone. Results. Differences between the plaintiff's and defendant's experts' opinions are presented by utilizing the COAT literature. Options for avoiding allegations of abandonment are proposed. Conclusions. To avoidand protect themselves against potential abandonment allegations when termination of the physician-patient relationship is warranted, physicians are advised to consider following the outlined procedures.

KW - Abandonment

KW - Aberrant drug-related behaviors

KW - Breaches of standards

KW - Chronic opioid analgesic therapy

KW - Chronic Pain

KW - Death

KW - Diversion

KW - Intractable pain

KW - Opioids

KW - Standards of medical care

KW - Suicide

UR - http://www.scopus.com/inward/record.url?scp=67049116489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67049116489&partnerID=8YFLogxK

U2 - 10.1111/j.1526-4637.2009.00620.x

DO - 10.1111/j.1526-4637.2009.00620.x

M3 - Article

C2 - 19453957

AN - SCOPUS:67049116489

VL - 10

SP - 722

EP - 729

JO - Pain Medicine

JF - Pain Medicine

SN - 1526-2375

IS - 4

ER -